Lck Antibody [P2J8]

Catalog No.: F7808

    Application: Reactivity:
    • Lane 1: Raji, Lane 2: Ramos, Lane 3: Jurka, Lane 4: Mouse thymus
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:30
    1:1000
    1:100
    1:500
    Application
    WB, IP, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    58 kDa 58 kDa, 60 kDa,36 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Lck Antibody [P2J8] detects endogenous levels of total Lck protein.
    Clone
    P2J8
    Synonym(s)
    Tyrosine-protein kinase Lck, Leukocyte C-terminal Src kinase, T cell-specific protein-tyrosine kinase, p56-LCK, LSK, LCK
    Background
    Lck is a Src family non‑receptor tyrosine kinase that localizes mainly to the inner leaflet of the plasma membrane of T lineage cells where it functions as a primary initiator and amplifier of T cell receptor signaling and contributes to additional receptor pathways that regulate development, activation, and effector function. The protein contains an N‑terminal myristoylation and palmitoylation region that targets it to membranes, followed by SH3 and SH2 domains that engage proline‑rich and phosphotyrosine‑containing motifs in partner proteins, and a C‑terminal kinase domain whose activity is controlled by intramolecular interactions governed by phosphorylation of the activation loop tyrosine and the C‑terminal inhibitory tyrosine. Association of Lck with the cytoplasmic tails of CD4 and CD8 co‑receptors positions the kinase adjacent to the TCR–CD3 complex during antigen recognition, where it phosphorylates immunoreceptor tyrosine‑based activation motifs within CD3 and ζ‑chains, creating docking sites for the Syk family kinase ZAP‑70 and initiating a cascade that recruits adaptor proteins such as LAT and SLP‑76 to assemble multi‑component signalosomes at the immune synapse. Catalytic activity of Lck integrates positive input from dephosphorylation of the C‑terminal inhibitory tyrosine and phosphorylation of the activation loop with negative regulation through Csk‑mediated phosphorylation and inhibitory protein interactions, establishing a tunable threshold for TCR signaling that influences thymic selection, peripheral activation, and sensitivity to antigen. Downstream of the TCR, Lck‑dependent phosphorylation events control multiple effector branches, including PLCγ1 activation with consequent calcium mobilization, Ras–MAPK pathway engagement, and activation of transcription factors such as NF‑AT, AP‑1, and NF‑κB, linking early membrane‑proximal kinase activity to gene expression programs that drive proliferation, differentiation, and cytokine production. The SH3 domain of Lck contributes specifically to coupling of proximal TCR phosphorylation to activation of the Ras–ERK arm of the MAPK pathway, illustrating that discrete structural modules within the kinase differentially regulate signaling outputs while leaving other branches such as calcium flux relatively intact when perturbed. Lck not only transduces TCR signals but also participates in co‑stimulatory and cytokine receptor pathways, including IL‑2 receptor signaling and CD2‑dependent activation, expanding its influence across multiple receptor systems that shape T cell expansion and functional polarization. Aberrant Lck activity or expression is linked to immunodeficiency, where insufficient signaling impairs thymocyte maturation and peripheral T cell responsiveness, and to autoimmunity and T cell malignancies, where excessive or deregulated activity contributes to pathological activation, chronic NF‑κB signaling, and oncogenic transformation.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください